Mitesh J. Borad, MD, on Managing Hepatocellular Cancers: What Clinicians Need to Know

Posted: Tuesday, April 18, 2023

Mitesh J. Borad, MD, of the Mayo Clinic Comprehensive Cancer Center, discusses what clinicians need to know about the treatment guidelines for diagnosing and staging hepatocellular cancers, how a patient’s hepatic reserve or risk category (Child-Pugh) may help guide treatment selection, and whether molecular profiling should be used to select among systemic therapies.

---